# An honour that redefines what matters in health-tech

- Link: https://www.directorstalkinterviews.com/an-honour-that-redefines-what-matters-in-health-tech/4121202949
- Published: 2025-06-19T10:12:00+01:00
- Author: Amilia Stone

From behind the scenes of health‑tech innovation, a distinguished leader steps into
the spotlight, her journey marked not by fanfare but by substance.

As founder and chief executive of a company that translates patient voices into 
actionable healthcare insights, Jo Halliday has been honoured with an MBE in the
King’s Birthday Honours List of June 2025. This recognition, officially recorded
as “Jo‑Anne HALLIDAY, Chief Executive Officer, Talking Medicines. For services to
the Economy and to Medical Innovation”, reflects a remarkable convergence of entrepreneurship,
data science and patient‑centric design.

Halliday’s work has consistently challenged the status quo in healthcare analytics.
Under her leadership, her company pioneered solutions that harness unstructured 
patient narratives, such as forum discussions and social media comments, and transform
them into structured insights. This empowers pharmaceutical companies and healthcare
agencies to better understand real-world patient experiences, shaping drug development,
marketing strategies, and policy decisions.

Rooted in a deep appreciation for both patient advocacy and commercial acumen, her
vision has steered the business toward sustained growth. The company has expanded
globally, attracting both industry interest and commercial partnerships across the
US and Europe. Its tools go beyond passive data aggregation; they actively decode
sentiment, unmet needs, and treatment patterns in real time, giving clients a clearer
understanding of patient communities.

For investors, Halliday’s MBE signals more than a personal achievement; it emphasises
the strategic value of a business operating at the intersection of technology, healthcare
and regulation. Recognition from the Crown underscores the UK’s growing emphasis
on innovation-driven economic growth and validation that patient‑focused data solutions
hold national significance. That institutional endorsement is likely to reinforce
trust among stakeholders across the healthcare industry, from regulators and payers
to commercial partners.

Moreover, the accolade comes at a pivotal time. As regulators call for greater patient
involvement in drug approval processes and healthcare systems become more reliant
on real-world evidence, the need for platforms that systematically mine patient 
sentiment has only grown. Halliday’s firm is well positioned to ride this wave, 
backed by its leadership in natural language processing and AI applied to complex
medical narratives—capabilities unveiled under her guidance earlier this year.

This honour also highlights a broader entrepreneurial narrative. Halliday has navigated
the common tension between technological hype and actionable value, establishing
credibility through validated outcomes rather than unsubstantiated promise. As a
CEO, she has balanced the demands of scaling data solutions, securing partnerships,
and safeguarding compliance, all while keeping the patient perspective central. 
It’s this measured yet ambitious approach that sets her apart and appeals to mission‑
driven investors.

This recognition from the King’s Birthday Honours comes at a time when the health‑
tech sector faces questions around scalability, regulatory scrutiny, and measurable
impact. Halliday’s MBE suggests a resolution of those challenges—through a combination
of technical rigour, commercial traction, and public legitimacy. For investors tracking
companies that bridge healthcare, AI and patient engagement, it’s a signal worth
noting.

Talking Medicines leverages AI and NLP to convert patient conversations into structured
insights. Their platform helps pharmaceutical and healthcare agencies understand
real-world treatment experiences, informing development, marketing, patient support,
and policy, bringing the patient voice to the centre of decision-making.

_**[Tern plc](https://www.directorstalkinterviews.com/company/tern-plc/tern.l) **(
[LON:TERN](https://www.directorstalkinterviews.com/company/tern-plc/tern.l)) backs
exciting, high growth IoT innovators in Europe. They provide support and create 
a genuinely collaborative environment for talented, well-motivated teams. _

Share on:
